Expertise in
1
conditions

Zafar I. Malik

Liverpool, ENG, GB 
Expertise in
1
conditions
Liverpool, ENG, GB 
OverviewLocationsClinical Research

Overview

Zafar Malik practices in Liverpool, United Kingdom. Mr. Malik is highly rated in 1 condition, according to our data. His top areas of expertise are Prostate Cancer, Febrile Neutropenia, Esophageal Perforation, Orchiectomy, and Prostatectomy.

His clinical research consists of co-authoring 37 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Liverpool, ENG, United Kingdom
Other Locations
Wirral, ENG, United Kingdom
Birkenhead, ENG, United Kingdom
Bebington, ENG, United Kingdom
Whiston, ENG, United Kingdom
King's College London And Guy's And St. Thomas' NHS Foundation Trust, St. James's University Hospital, Derby, Weston Park Hospital, Portsmouth, Musgrove Park Hospital, Hull, Mount Vernon Cancer Centre, Manchester, ENG, United Kingdom
London, ENG, United Kingdom
Prescot, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Randomised Phase 3 Trial of Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer: ENZARAD
Randomised Phase 3 Trial of Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer: ENZARAD
Enrollment Status: Active_not_recruiting
Publish Date: May 30, 2025
Intervention Type: Drug, Radiation
Study Drugs: Enzalutamide, Conventional NSAA, LHRHA
Study Phase: Phase 3

37 Total Publications

Corrigendum to "A comparison of the efficacy of trastuzumab deruxtecan in advanced HER2-positive breast cancer: active brain metastasis versus progressive extracranial disease alone": [ESMO Open 8 (2023) 102033].
Corrigendum to "A comparison of the efficacy of trastuzumab deruxtecan in advanced HER2-positive breast cancer: active brain metastasis versus progressive extracranial disease alone": [ESMO Open 8 (2023) 102033].
Journal: ESMO open
Published: June 13, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Malik's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile